Gaudium IVF & Women Health
add_icon

Gaudium IVF & Women Health

121.47
+5.78
(5.00%)
Market Cap
884.14 Cr
PE Ratio
37.08
Volume
4,66,216.00
Day High - Low
121.47 - 109.91
52W High-Low
133.00 - 69.18
hide
Key Fundamentals
Add Ratio
split_icon_default
Market Cap
884.14 Cr
EPS
3.12
PE Ratio
37.08
PB Ratio
5.66
Book Value
20.45
EBITDA
28.90
Dividend Yield
0.00 %
Industry
Healthcare
Return on Equity
41.31
Debt to Equity
0.52
Forecast For
Actual

Company News

View All News
Caret
neutral
Gaudium IVF and Women Health Limited responds to stock exchange queries about share price volatility, confirming no undisclosed price sensitive information exists and movement is purely market driven.
positive
Gaudium IVF and Women Health Limited announces Corporate Identification Number change from unlisted to listed status following equity shares listing on NSE and BSE exchanges.
neutral
Gaudium IVF and Women Health Limited submits compliance certificate under SEBI regulations for Q4FY26, with registrar confirming non-applicability due to full dematerialization.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,367.20
#1 22,908.12
43.92
#1 2,554.80
11.28
#1 492
-6.83
44.66
1,129.60
11,623.21
71.61
699.70
23.06
144
22.38
80.72
476.50
9,879.17
58.64
1,346.30
10.64
146
33.65
56.51
400.30
6,371.39
47.37
702.20
20.80
91
47.37
55.96
529.25
5,310.53
74.65
769.90
33.97
67
60.20
43.88
588.75
1,909.83
23.41
742.70
16.70
78
-21.13
45.96
283.95
1,478.83
45.35
255.90
15.11
31
20.00
61.15
544.65
1,064.40
#1 16.41
147.80
#1 134.60
19
#1 520.00
45.78
1,199.30
1,029.32
18.70
111.60
28.72
48
65.93
-
281.75
896.26
30.77
1,170.80
-18.47
-134
101.06
59.28
Growth Rate
Revenue Growth
32.22 %
Net Income Growth
15.06 %
Cash Flow Change
153.49 %
ROE
-17.21 %
ROCE
-15.64 %
EBITDA Margin (Avg.)
-15.34 %

Quarterly Financial Results

Quarterly Financials
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Revenue
14
27
18
32
25
Expenses
9
18
13
18
18
EBITDA
6
9
5
14
7
Operating Profit %
39 %
33 %
29 %
43 %
27 %
Depreciation
1
0
1
1
1
Interest
0
0
1
1
1
Profit Before Tax
5
8
4
13
5
Tax
1
2
1
3
1
Net Profit
3
7
3
9
4
EPS in ₹
0.55
1.07
0.51
1.53
0.59

Balance Sheet

Balance Sheet
2022
2023
2024
2025
Total Assets
18
37
57
89
Fixed Assets
4
18
19
18
Current Assets
14
18
38
54
Capital Work in Progress
0
0
0
7
Investments
0
0
0
5
Other Assets
14
18
39
58
Total Equity & Liabilities
18
37
57
89
Current Liabilities
6
10
20
38
Non Current Liabilities
3
4
4
4
Total Equity
9
23
33
46
Reserve & Surplus
8
22
32
16
Share Capital
1
1
1
31

Cash Flow

Cash Flow
2022
2023
2024
2025
Net Cash Flow
0
14
-3
-5
Investing Activities
-1
-16
-5
-15
Operating Activities
-1
24
3
9
Financing Activities
3
5
-1
2

Share Holding

% Holding
Jan 2025
Sept 2025
Feb 2026
Mar 2026
Promoter
99.98 %
99.98 %
71.29 %
71.29 %
FIIs
0.00 %
0.00 %
9.24 %
6.70 %
DIIs
0.00 %
0.00 %
5.11 %
2.62 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
0.00 %
13.52 %
14.67 %
Others
0.02 %
0.02 %
0.84 %
4.73 %
No of Share Holders
7
7
7
19,854

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
18 Mar 2026 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
18 Mar 2026 81.09 85.19

Announcements

Clarification On Price MovementApr 16, 2026
Clarification sought from Gaudium IVF and Women Health LtdApr 16, 2026
Intimation Regarding Change Of Corporate Identification Number Of The CompanyApr 15, 2026
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Apr 10, 2026
Gaudium IVF And Women Health Limited Has Updated The Exchange On The Query Received From BSE Limited Vide Its Email Dated April 07 2026 Seeking Additional Details For Corporate Announcement Dated April 06 2026 Filed Under Regulation 30 Of SEBI (LODR) ReguApr 07, 2026
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 (Listing Regulations)Apr 06, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseApr 01, 2026
Intimation Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulation 2015 ( "Listing Regulations")Apr 01, 2026
Closure of Trading WindowMar 28, 2026
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMar 19, 2026
Announcement under Regulation 30 (LODR)-Newspaper PublicationMar 19, 2026
Announcement under Regulation 30 (LODR)-Change in ManagementMar 18, 2026
Board Meeting Outcome for Board Meeting Outcome For Standalone And Consolidated Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2025Mar 18, 2026
Standalone And Consolidated Unaudited Financial Results For The Quarter And Nine Months Ended December 31 2025Mar 18, 2026
Board Meeting Intimation for Consideration And Approval Of Unaudited Standalone And Consolidated Financial Results Of The Company For The Quarter And Nine Months Ended December 31 2025Mar 12, 2026
Intimation Under Regulation 8(2) Of The Securities And Exchange Board Of India (Prohibition Of Insider Trading) Regulations 2015Mar 02, 2026
Intimation Under Regulation 7(1) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 (SEBI Listing Regulations)Mar 02, 2026
Intimation Under Regulation 6(1) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015Mar 02, 2026
Intimation Under Regulation 30(5) Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 ("SEBI Listing Regulations")Mar 02, 2026
Closure of Trading WindowMar 02, 2026
Listing of Equity Shares of Gaudium IVF and Women Health LtdFeb 27, 2026

Technical Indicators

RSI(14)
Neutral
65.64
ATR(14)
Volatile
8.89
STOCH(9,6)
Neutral
76.50
STOCH RSI(14)
Neutral
41.26
MACD(12,26)
Bullish
2.41
ADX(14)
Strong Trend
36.89
UO(9)
Bearish
58.78
ROC(12)
Uptrend And Accelerating
26.23
WillR(14)
Neutral
-26.02